RESEARCH AND DEVELOPMENT
Development and commercialization of new, attractive APIs is the priority of the POLPHARMA API R&D Department. The key to our success is the combination of experience and expertise of our own research team as well as effective co-operation with scientific institutions.
57 highly qualified Professionals, including 16 with PhD degrees, are employed in API R&D Department:
5 R&D Management
13 New Process
12 Regulatory Service
Dept. & Prod. Doc.
R&D development approaches
- Project development strategy for early launch in FTO and launch in IP regulated territory
- Identification and differentiation in API in terms of CQA
- New Therapeutic Categories/Technologies
Acquisition of Technology and Technological Solutions
- to bridge the gap for Product launch
- integrated network with external competency centers
- Our strategy is based on partnerships which form and strengthen technology platforms for long-term growth, creating value for our customers.
- Partnerships with other companies and development houses offer new technologies, identify the best projects and drive costs down with environmental sustainability.